» Articles » PMID: 34297769

Targeted Capture Sequencing Identifies Genetic Variations of GRK4 and RDH8 in Han Chinese with Essential Hypertension in Xinjiang

Overview
Journal PLoS One
Date 2021 Jul 23
PMID 34297769
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Essential hypertension is a common cardiovascular disease with complex etiology, closely related to genetic and environmental factors. The pathogenesis of hypertension involves alteration in vascular resistance caused by sympathetic nervous system (SNS) and renin angiotensin system (RAS). Susceptibility factors of hypertension vary with regions and ethnicities. In this study, we conducted target capture sequencing on 54 genes related to SNS and RAS derived from a collection of Han nationality, consisting of 151 hypertension patients and 65 normal subjects in Xinjiang, China. Six non-synonymous mutations related to hypertension were identified, including GRK4 rs1644731 and RDH8 rs1801058, Mutations are predicted to affect 3D conformation, force field, transmembrane domain and RNA secondary structure of corresponding genes. Based on protein interaction network and pathway enrichment, GRK4 is predicted to participate in hypertension by acting on dopaminergic synapse, together with interacting components. RDH8 is involved in vitamin A (retinol) metabolism and consequent biological processes related to hypertension. Thus, GRK4 and RDH8 may serve as susceptibility genes for hypertension. This finding provides new genetic evidence for elucidating risk factors of hypertension in Han nationality in Xinjiang, which in turn, enriches genetic resource bank of hypertension susceptibility genes.

Citing Articles

G protein-coupled receptor kinases in hypertension: physiology, pathogenesis, and therapeutic targets.

Zhang F, Armando I, Jose P, Zeng C, Yang J Hypertens Res. 2024; 47(9):2317-2336.

PMID: 38961282 PMC: 11374685. DOI: 10.1038/s41440-024-01763-y.


Dopamine Receptor DR and DR and GRK4 Interaction in Hypertension.

Zeng C, Armando I, Yang J, Jose P Yale J Biol Med. 2023; 96(1):95-105.

PMID: 37009199 PMC: 10052590. DOI: 10.59249/MKRR9549.


Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics.

Yang J, Hall J, Jose P, Chen K, Zeng C Pharmacol Ther. 2022; 239:108194.

PMID: 35487286 PMC: 9728143. DOI: 10.1016/j.pharmthera.2022.108194.

References
1.
Villar V, Jones J, Armando I, Palmes-Saloma C, Yu P, Pascua A . G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor. J Biol Chem. 2009; 284(32):21425-34. PMC: 2755867. DOI: 10.1074/jbc.M109.003665. View

2.
Bovolenta L, Acencio M, Lemke N . HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions. BMC Genomics. 2012; 13:405. PMC: 3472291. DOI: 10.1186/1471-2164-13-405. View

3.
Keshava Prasad T, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S . Human Protein Reference Database--2009 update. Nucleic Acids Res. 2008; 37(Database issue):D767-72. PMC: 2686490. DOI: 10.1093/nar/gkn892. View

4.
Liu C, Xi B . Pooled analyses of the associations of polymorphisms in the GRK4 and EMILIN1 genes with hypertension risk. Int J Med Sci. 2012; 9(4):274-9. PMC: 3360431. DOI: 10.7150/ijms.4171. View

5.
Beetz N, Harrison M, Brede M, Zong X, Urbanski M, Sietmann A . Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J Clin Invest. 2009; 119(12):3597-3612. PMC: 2786789. DOI: 10.1172/JCI38433. View